Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. [...]
The post Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen appeared first on Community Pharmacy England.
Recent Comments